CYTKNasdaq United States
Market cap
$9.551 B
$76.76 -5.67%
Close of 7 Aug 2026
Revenue
$88.0M
#2559 by revenue
Earnings
-$785.0M
Loss-making
Shares outstanding
139,023,418
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cytokinetics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.